Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for Bertilimumab for the Treatment of Bullous Pemphigoid
IMMUNE PHARMACEUTICALS INC NE (IMNP)
US:NASDAQ Investor Relations:
immunepharma.com/investor-relations
Company Research
Source: GlobeNewswire
ENGLEWOOD CLIFFS, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the Company’s application for Orphan Drug Designation for bertilimumab for the treatment of bullous pemphigoid (BP). “We are pleased that the COMP has issued its opinion in support of our request for orphan designation for bertilimumab for the treatment of bullous pemphigoid.” commented Immune’s Chief Medical and Operating Officer, Tony Fiorino, MD, PhD. “Our data suggest that blocking eotaxin-1 can have important clinical benefits for patients with moderate-to-extensive disease. We intend to make use of the enhanced regulatory support enabled by receiving orphan drug designation from the EM
Show less
Read more
Impact Snapshot
Event Time:
IMNP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNP alerts
High impacting IMMUNE PHARMACEUTICALS INC NE news events
Weekly update
A roundup of the hottest topics